The Marked Chart Wire · Health
Merck
EU committee backs Merck's kidney cancer drug combination
The European Medicines Agency panel advised approving Welireg alongside lenvatinib for late-stage kidney tumors. A final ruling from Brussels is anticipated in the next two months.
